Care and outcomes of atrial fibrillation in potentially vulnerable populations: A 20-year perspective using real-world data

29 August 2025 (16:35 - 16:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Miss Nina Nouhravesh

Duke Clinical Research Institute, Durham (United States of America)

4 More presentations in this session

Presentation thumbnail

Prognostic implications of atrial fibrillation in young patients without overt heart disease - an early marker of future cardiomyopathy ?

Doctor P. Rasmussen (Copenhagen, DK)

Abstract Slides Video

Presentation thumbnail

Integrating pre- and post-ablation B-type natriuretic peptide to identify high-risk population for long-term adverse events and arrhythmic recurrence in persistent atrial fibrillation

Doctor S. Hashimoto (Ube, JP)

Abstract Slides Video

Presentation thumbnail

Tachycardiomyopathy is associated with metabolic changes that predict LVEF recovery - results from the EMPATHY study

Doctor D. Heinzmann (Tuebingen, DE)

Abstract Slides Video

Presentation thumbnail

ECG changes predict new-onset heart failure in patients with atrial fibrillation.

Doctor C. Binding (Copenhagen, DK)

Abstract Slides Video

Access the full session

Session thumbnail

Atrial fibrillation and heart failure: a deadly combination

The Event

Event poster

ESC Congress 2025

29 August 2025 16:35 CET

You may be interested in

Congress Presentation

Temporal trends in initiation of oral anticoagulants and stroke-free survival among elderly and very elderly patients with new onset atrial fibrillation - a 20-year perspective.

Congress Session

Stroke risk management in atrial fibrillation registries: key take-home messages for clinicians

Congress Presentation

The global burden of atrial fibrillation: implications for risk assessments and outcomes

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources